Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Study
  • Published:

Maintaining remission in a patient with vasculitis

Nature Clinical Practice Rheumatology volume 4, pages 499–504 (2008)Cite this article

Abstract

Background A 40-year-old man was referred to a specialist vasculitis center 4 years after being diagnosed with Wegener's granulomatosis. At the time of diagnosis he had presented with skin, ear, nose and throat involvement, pulmonary hemorrhage, and microscopic hematuria. Remission was achieved with plasma exchange and with daily oral prednisolone and cyclophosphamide. The patient was switched to maintenance treatment with azathioprine and prednisolone but suffered a relapse shortly afterwards. Further treatment with cyclophosphamide achieved a second remission, but the patient relapsed again despite remission-maintaining treatment with mycophenolate mofetil.

Investigations Physical examination, laboratory testing, serological testing, culture of eye swabs and sputum, chest X-ray, chest CT scan, head MRI scan, bronchoscopy and bronchoalveolar lavage, and consultation with ophthalmological and otorhinolaryngological specialists.

Diagnosis Refractory Wegener's granulomatosis with involvement of the eyes, upper and lower respiratory tracts, and kidneys.

Management Disease activity was controlled following treatment with deoxyspergualin and oral steroids in addition to aggressive management of intercurrent infections with repeated courses of oral and intravenous antibiotics. Relapses that occurred when deoxyspergualin was discontinued were treated with repeated courses of deoxyspergualin or with pulsed intravenous cyclophosphamide. Remission was achieved with rituximab. Pulmonary disease was closely monitored with repeated bronchoscopy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Serial chest X-rays and a CT scan of a patient with Wegener's granulomatosis.
Figure 2: The course of disease activity in a patient with Wegener's granulomatosis and the treatment decisions taken.

References

  1. Jennette JC et al. (1994) Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 37: 187–192

    Article  CAS  Google Scholar 

  2. Jayne D et al. (2003) A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. N Engl J Med 349: 36–44

    Article  CAS  Google Scholar 

  3. Jayne DR et al. (2007) Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. J Am Soc Nephrol 18: 2180–2188

    Article  CAS  Google Scholar 

  4. Luqmani RA et al. (1994) Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM 87: 671–678

    CAS  PubMed  Google Scholar 

  5. Cordier JF et al. (1990) Pulmonary Wegener's granulomatosis: a clinical and imaging study of 77 cases. Chest 97: 906–912

    Article  CAS  Google Scholar 

  6. Hellmich B et al. (2007) EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 66: 605–617

    Article  CAS  Google Scholar 

  7. Reinhold-Keller E et al. (2000) An interdisciplinary approach to the care of patients with Wegener's granulomatosis: long-term outcome in 155 patients. Arthritis Rheum 43: 1021–1032

    Article  CAS  Google Scholar 

  8. Stegeman CA et al. (1994) Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 120: 12–17

    Article  CAS  Google Scholar 

  9. Lapraik C et al. (2007) BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis. Rheumatology (Oxford) 46: 1615–1616

    Article  CAS  Google Scholar 

  10. Hoffman GS et al. (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116: 488–498

    Article  CAS  Google Scholar 

  11. de Groot K et al. (2001) The value of pulse cyclophosphamide in ANCA-associated vasculitis: meta-analysis and critical review. Nephrol Dial Transplant 16: 2018–2027

    Article  CAS  Google Scholar 

  12. de Groot K et al. (2005) Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 52: 2461–2469

    Article  CAS  Google Scholar 

  13. Koukoulaki M and Jayne DR (2006) Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis. Nephron Clin Pract 102: c100–c107

    Article  CAS  Google Scholar 

  14. Birck R et al. (2003) 15-Deoxyspergualin in patients with refractory ANCA-associated systemic vasculitis: a six-month open-label trial to evaluate safety and efficacy. J Am Soc Nephrol 14: 440–447

    Article  CAS  Google Scholar 

  15. Schmitt WH et al. (2005) Prolonged treatment of refractory Wegener's granulomatosis with 15-deoxyspergualin: an open study in seven patients. Nephrol Dial Transplant 20: 1083–1092

    Article  CAS  Google Scholar 

  16. Smith KG et al. (2006) Long-term comparison of rituximab treatment for refractory systemic lupus erythematosus and vasculitis: remission, relapse, and re-treatment. Arthritis Rheum 54: 2970–2982

    Article  CAS  Google Scholar 

  17. Keogh KA et al. (2006) Rituximab for refractory Wegener's granulomatosis: report of a prospective, open-label pilot trial. Am J Respir Crit Care Med 173: 180–187

    Article  CAS  Google Scholar 

  18. Stasi R et al. (2006) Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab. Rheumatology (Oxford) 45: 1432–1436

    Article  CAS  Google Scholar 

  19. Metzler C et al. (2007) Elevated relapse rate under oral methotrexate versus leflunomide for maintenance of remission in Wegener's granulomatosis. Rheumatology (Oxford) 46: 1087–1091

    Article  CAS  Google Scholar 

  20. Stegeman CA et al. for the Dutch Co-Trimoxazole Wegener Study Group (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335: 16–20

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. O Flossmann is a Specialist Registrar in Nephrology and General Medicine and DRW Jayne is a Consultant Nephrologist and Head of the Vasculitis and Lupus Unit at Addenbrooke's Hospital, Cambridge, UK.,

    Oliver Flossmann & David RW Jayne

Authors
  1. Oliver Flossmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. David RW Jayne
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Oliver Flossmann.

Ethics declarations

Competing interests

O Flossmann has received consultant fees and grant support from Nippon Kayaku. DRW Jayne has received consultant fees from Aspreva, Nippon Kayaku and Roche.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Flossmann, O., Jayne, D. Maintaining remission in a patient with vasculitis. Nat Rev Rheumatol 4, 499–504 (2008). https://doi.org/10.1038/ncprheum0863

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncprheum0863

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing